162 related articles for article (PubMed ID: 24717156)
1. Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy.
Kwa FA; Thrimawithana TR
Drug Discov Today; 2014 Sep; 19(9):1387-93. PubMed ID: 24717156
[TBL] [Abstract][Full Text] [Related]
2. Future Perspectives: Agents on the Horizon.
Maya JR; Sadiq MA; Agarwal A; Kaiser PK; Stoller GL; Sepah YJ; Nguyen QD
Dev Ophthalmol; 2016; 55():391-8. PubMed ID: 26501694
[TBL] [Abstract][Full Text] [Related]
3. Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases.
Choudhary M; Malek G
J Biomol Screen; 2016 Dec; 21(10):1007-1018. PubMed ID: 27455994
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic mechanisms in the pathogenesis of diabetic retinopathy.
Zeng J; Chen B
Ophthalmologica; 2014; 232(1):1-9. PubMed ID: 24714375
[TBL] [Abstract][Full Text] [Related]
5. Current drug patenting for retinal diseases: beyond VEGF inhibitors.
Mucke HA; Mucke PM
IDrugs; 2010 Jan; 13(1):30-7. PubMed ID: 20024845
[TBL] [Abstract][Full Text] [Related]
6. Models of retinal diseases and their applicability in drug discovery.
Malek G; Busik J; Grant MB; Choudhary M
Expert Opin Drug Discov; 2018 Apr; 13(4):359-377. PubMed ID: 29382242
[TBL] [Abstract][Full Text] [Related]
7. Targeting epigenetic modifications as a potential therapeutic option for diabetic retinopathy.
Kumari N; Karmakar A; Ganesan SK
J Cell Physiol; 2020 Mar; 235(3):1933-1947. PubMed ID: 31531859
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics in age-related macular degeneration: new discoveries and future perspectives.
Gemenetzi M; Lotery AJ
Cell Mol Life Sci; 2020 Mar; 77(5):807-818. PubMed ID: 31897542
[TBL] [Abstract][Full Text] [Related]
9. Drug delivery methods for posterior segment disease.
Hsu J
Curr Opin Ophthalmol; 2007 May; 18(3):235-9. PubMed ID: 17435432
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and epigenetics in ocular vascular aging: an updated review.
Zhao B; Zhu L; Ye M; Lou X; Mou Q; Hu Y; Zhang H; Zhao Y
Mol Med; 2023 Feb; 29(1):28. PubMed ID: 36849907
[TBL] [Abstract][Full Text] [Related]
11. Epigenomic signatures in age-related macular degeneration: Focus on their role as disease modifiers and therapeutic targets.
Caputo V; Strafella C; Termine A; Fabrizio C; Ruffo P; Cusumano A; Giardina E; Ricci F; Cascella R
Eur J Ophthalmol; 2021 Nov; 31(6):2856-2867. PubMed ID: 34798695
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation plays important roles in retinal development and diseases.
Wu J; Liu LL; Cao M; Hu A; Hu D; Luo Y; Wang H; Zhong JN
Exp Eye Res; 2021 Oct; 211():108733. PubMed ID: 34418429
[TBL] [Abstract][Full Text] [Related]
13. Potential drug interventions for diabetic retinopathy.
Shen Q; Wu JZ; Wong JC
Drug Discov Today; 2013 Dec; 18(23-24):1334-41. PubMed ID: 24012972
[TBL] [Abstract][Full Text] [Related]
14. [New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia].
Rejdak R; Szkaradek M; Taslaq W; Kałuzny JJ; Grieb P; Jünemann AG
Klin Oczna; 2012; 114(4):308-10. PubMed ID: 23461161
[TBL] [Abstract][Full Text] [Related]
15. Diabetic retinopathy and age-related macular degeneration in the U.S.
Gibson DM
Am J Prev Med; 2012 Jul; 43(1):48-54. PubMed ID: 22704745
[TBL] [Abstract][Full Text] [Related]
16. Potential of epigenetic mechanisms in AMD pathology.
Blasiak J; Salminen A; Kaarniranta K
Front Biosci (Schol Ed); 2013 Jan; 5(2):412-25. PubMed ID: 23277059
[TBL] [Abstract][Full Text] [Related]
17. AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies.
Castro BFM; Steel JC; Layton CJ
BioDrugs; 2024 Jan; 38(1):73-93. PubMed ID: 37878215
[TBL] [Abstract][Full Text] [Related]
18. Contribution of epigenetics in diabetic retinopathy.
Kowluru RA; Mishra M
Sci China Life Sci; 2015 Jun; 58(6):556-63. PubMed ID: 26025281
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of age-related macular degeneration and therapeutic opportunities.
van Lookeren Campagne M; LeCouter J; Yaspan BL; Ye W
J Pathol; 2014 Jan; 232(2):151-64. PubMed ID: 24105633
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging therapies for ocular neovascularisation.
Reynolds AL; Kent D; Kennedy BN
Adv Exp Med Biol; 2014; 801():797-804. PubMed ID: 24664773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
